These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36124425)

  • 1. Toward equitable utilization of durable left ventricular assist device therapy in advanced heart failure-Raising the veil of health disparities.
    Mazimba S
    J Card Surg; 2022 Nov; 37(11):3595-3597. PubMed ID: 36124425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporary left ventricular assist devices as a bridge to heart transplantation.
    Seese L; Hickey G; Keebler ME; Mathier MA; Sultan I; Gleason TG; Wang Y; Kilic A
    J Card Surg; 2020 Apr; 35(4):810-817. PubMed ID: 32092194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes with ambulatory advanced heart failure from the Medical Arm of Mechanically Assisted Circulatory Support (MedaMACS) Registry.
    Ambardekar AV; Kittleson MM; Palardy M; Mountis MM; Forde-McLean RC; DeVore AD; Pamboukian SV; Thibodeau JT; Teuteberg JJ; Cadaret L; Xie R; Taddei-Peters W; Naftel DC; Kirklin JK; Stevenson LW; Stewart GC
    J Heart Lung Transplant; 2019 Apr; 38(4):408-417. PubMed ID: 30948210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A roadmap for evaluating the use and value of durable ventricular assist device therapy.
    Ward ST; Liang Q; Pagani FD; Zhang M; Kormos RL; Aaronson KD; Althouse AD; Nallamothu BK; Likosky DS
    J Heart Lung Transplant; 2018 Jan; 37(1):146-150. PubMed ID: 28711453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in patients undergoing heart transplantation and LVAD therapy.
    Rubinstein G; Lotan D; Moeller CM; DeFilippis EM; Slomovich S; Oren D; Yuzefpolskaya M; Sayer G; Uriel N
    Expert Rev Cardiovasc Ther; 2022 Nov; 20(11):881-894. PubMed ID: 36409479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
    Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in disease-specific versus generic health status measures after left ventricular assist device implantation: Insights from INTERMACS.
    Nassif ME; Spertus JA; Jones PG; Fendler TJ; Allen LA; Grady KL; Arnold SV
    J Heart Lung Transplant; 2017 Nov; 36(11):1243-1249. PubMed ID: 28662987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes.
    Gustafsson F; Rogers JG
    Eur J Heart Fail; 2017 May; 19(5):595-602. PubMed ID: 28198133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of left ventricular assist devices and heart transplants on acute myocardial infarction and heart failure mortality and readmission measures.
    Brandt EJ; Ross JS; Grady JN; Ahmad T; Pawar S; Bernheim SM; Desai NR
    PLoS One; 2020; 15(3):e0230734. PubMed ID: 32214363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparities in Practice Patterns by Sex, Race, and Ethnicity in Patients Referred for Advanced Heart Failure Therapies.
    Herr JJ; Sheikh FH; Patel PJ; Lala A; Chien CV; Hsiao S; Srivastava A; Pedrotty D; Nowaczyk J; Tompkins S; Ahmed S; Xiang F; Forest S; Tong MZ; Kamdar F; D'Souza B; Ravichandran A;
    Am J Cardiol; 2022 Dec; 185():46-52. PubMed ID: 36280472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparities and Impact of Medicaid Expansion on Left Ventricular Assist Device Implantation and Outcomes.
    Wang X; Luke AA; Vader JM; Maddox TM; Joynt Maddox KE
    Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006284. PubMed ID: 32394720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current indications for heart transplantation and left ventricular assist device: a practical point of view.
    Ammirati E; Oliva F; Cannata A; Contri R; Colombo T; Martinelli L; Frigerio M
    Eur J Intern Med; 2014 Jun; 25(5):422-9. PubMed ID: 24641806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High early event rates in patients with questionable eligibility for advanced heart failure therapies: Results from the Medical Arm of Mechanically Assisted Circulatory Support (Medamacs) Registry.
    Ambardekar AV; Forde-McLean RC; Kittleson MM; Stewart GC; Palardy M; Thibodeau JT; DeVore AD; Mountis MM; Cadaret L; Teuteberg JJ; Pamboukian SV; Cantor RS; Lindenfeld J
    J Heart Lung Transplant; 2016 Jun; 35(6):722-30. PubMed ID: 26987599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial and Sex Inequities in the Use of and Outcomes After Left Ventricular Assist Device Implantation Among Medicare Beneficiaries.
    Cascino TM; Somanchi S; Colvin M; Chung GS; Brescia AA; Pienta M; Thompson MP; Stewart JW; Sukul D; Watkins DC; Pagani FD; Likosky DS; Aaronson KD; McCullough JS
    JAMA Netw Open; 2022 Jul; 5(7):e2223080. PubMed ID: 35895063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation.
    Ammirati E; Cipriani MG; Varrenti M; Colombo T; Garascia A; Cannata A; Pedrazzini G; Benazzi E; Milazzo F; Oliva F; Gagliardone MP; Russo CF; Frigerio M
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):584-92. PubMed ID: 27245619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Racial disparities and outcomes of left ventricular assist device implantation as a bridge to heart transplantation.
    Okoh AK; Selevanny M; Singh S; Hirji S; Singh S; Al Obaidi N; Lee LY; Camacho M; Russo MJ
    ESC Heart Fail; 2020 Oct; 7(5):2744-2751. PubMed ID: 32627939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of a left ventricular assist device as destination therapy versus guideline-directed medical therapy in patients with advanced heart failure. Rationale and design of the SWEdish evaluation of left Ventricular Assist Device (SweVAD) trial.
    Karason K; Lund LH; Dalén M; Björklund E; Grinnemo K; Braun O; Nilsson J; van der Wal H; Holm J; Hübbert L; Lindmark K; Szabo B; Holmberg E; Dellgren G;
    Eur J Heart Fail; 2020 Apr; 22(4):739-750. PubMed ID: 32100946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical presentation and outcomes in women and men with advanced heart failure.
    Vishram-Nielsen JKK; Deis T; Rossing K; Wolsk E; Alba AC; Gustafsson F
    Scand Cardiovasc J; 2020 Dec; 54(6):361-368. PubMed ID: 32666856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart Transplantation After Ventricular Assist Device Therapy: Benefits, Risks, and Outcomes.
    Pal N; Gay SH; Boland CG; Lim AC
    Semin Cardiothorac Vasc Anesth; 2020 Mar; 24(1):9-23. PubMed ID: 31928333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.